Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience | SpringerLink
Role of biological agents in treatment of rheumatoid arthritis - ScienceDirect
A review of the totality of evidence in the development of ABP 798, a rituximab biosimilar | Immunotherapy
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Mechanism of action of rituximab. Rituximab is a monoclonal antibody... | Download Scientific Diagram
A review of the current use of rituximab in autoimmune diseases - ScienceDirect
Empowering Targeted Therapy: Lessons from Rituximab | Science's STKE
Rituximab-related Severe Toxicity | SpringerLink
The value of rituximab treatment in primary Sjögren's syndrome - ScienceDirect
Rituximab Use in Pediatric Dermatology - JDDonline - Journal of Drugs in Dermatology
Novel therapeutic targets in rheumatoid arthritis: Trends in Pharmacological Sciences
Biological Therapy for Rheumatoid Arthritis - ppt download
Cells | Free Full-Text | Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment
JPM | Free Full-Text | Using the Immunophenotype to Predict Response to Biologic Drugs in Rheumatoid Arthritis
RA | RITUXAN® (rituximab) Proposed Mechanism of Action (MoA) in Rheumatoid Arthritis
Rituximab - Wikipedia
Anti‐CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis - Korhonen - 2010 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
Truxima (rituximab) for the Treatment of Cancer - Clinical Trials Arena
Rituximab (Rituxan) | American Journal of Neuroradiology
B-Cell Targeted Therapies: Clinical Trials Update
Internet Scientific Publications
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective | Critical Care | Full Text
Rituximab in dermatology | Actas Dermo-Sifiliográficas
Targeting CD20: Monoclonals of the future - ppt download
